Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-23-000024

Chief R&D Officer gave up 3,907 shares (to pay taxes)

  • Chief R&D Officer acquired 13,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scopelianos Angelo · Chief R&D Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-16 Exercise or conversion : show line 1 in the form +8,250 34,208 D
2023-03-16 Exercise or conversion : show line 2 in the form +3,000 37,208 D
2023-03-16 Exercise or conversion : show line 3 in the form +2,500 39,708 D
2023-03-16 Shares withheld for taxes : show line 4 in the form −2,196 $8.27 $18,161 37,512 D
2023-03-16 Shares withheld for taxes : show line 5 in the form −778 $8.27 $6,434 36,734 D
2023-03-16 Shares withheld for taxes : show line 6 in the form −933 $8.27 $7,716 35,801 D

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2023-03-16 Exercise or conversion : show line 7 in the form Restricted Stock Units −8,250 8,250 D
2023-03-16 Exercise or conversion : show line 8 in the form Restricted Stock Units −3,000 3,000 D
2023-03-16 Exercise or conversion : show line 9 in the form Restricted Stock Units −2,500 2,500 D
2023-03-16 Grant or award : show line 10 in the form Employee Stock Option (right to purchase) +78,000 78,000 D
2023-03-16 Grant or award : show line 11 in the form Restricted Stock Units +54,100 54,100 D
Loading xslF345X04/wf-form4_167935121279855.xml…